AKT1 and autoimmune thrombocytopenic purpura: In conclusion, our findings improved the understanding of the PI3K/Akt signaling pathway and, more significantly, suggest targeted therapeutic strategies and research direction for ITP caused by related genes mutation or other pathogenic factors.